Sodium Bicarbonate Antacid
NDC 71610-669, Sodium Bicarbonate, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-669
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M001
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM BICARBONATE650 mg/1
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-669-53 | 71610066953 | 60 TABLET in 1 BOTTLE (71610-669-53) |
| 71610-669-60 | 71610066960 | 90 TABLET in 1 BOTTLE (71610-669-60) |
| 71610-669-80 | 71610066980 | 180 TABLET in 1 BOTTLE (71610-669-80) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71610-669 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-669. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.